Clinical trial
Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men
NCT00385190 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00385190 |
|---|---|
| Title | Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men |
| Official title | An Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of Study Drug Administred Orally to Healthy Japanese Male Subjects |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | HCV-796 |
| Enrollment | 24 |
| Start date | Jul 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Oct 6, 2006 |
| Last update posted | Aug 18, 2009 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: